Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"cancer signaling"”.

  1. Genome-scale Precision Proteomics Identifies Cancer Signaling Networks and Therapeutic Vulnerabilities

    … then applied these advanced proteomics tools for cancer proteome analyses on high grade gliomas (HGG) and rhabdomyosarcomas (RMS). Using systems biology approaches, we demonstrated that these newly developed proteomic analysis pipelines are able to (i) define human proteotypes that link …

    tenn-hsc Repository record for Genome-scale Precision Proteomics Identifies Cancer Signaling Networks and Therapeutic Vulnerabilities (opens in a new tab)

  2. Hijacking Cancer Signaling: First-in-class JPRK-targeting Ligands for Fibrolamellar Hepatocellular Carcinoma

    … carcinoma is a rare un-treated liver cancer driven by a fusion kinase known as JPRK, a mutant of protein kinase A (PKA). Targeting this fusion kinase selectively is challenging due to the structural similarity of the catalytic domain to other kinases, most significantly, PKA, whose …

    toronto-retro Repository record for Hijacking Cancer Signaling: First-in-class JPRK-targeting Ligands for Fibrolamellar Hepatocellular Carcinoma (opens in a new tab)

  3. Aminoflavone Inhibits α6-integrin and Growth of Tamoxifen Resistant Breast Cancer

    … 40% of estrogen receptor positive (ER+) breast cancer patients develop resistance to standard of care agent tamoxifen, while ER negative (ER-) breast cancer patients are intrinsically resistant to tamoxifen. Resistance often promotes metastasis, recurrence and death. Tumor-initiating cells …

    loma-linda Repository record for Aminoflavone Inhibits α6-integrin and Growth of Tamoxifen Resistant Breast Cancer (opens in a new tab)

  4. Exploring the mechanism of SHP2 and EGFR/HER2 cooperation in breast cancer cell signaling

    … has been established as a critical mediator of cancer-related cell signaling downstream of receptor tyrosine kinases like EGFR and HER2. As such, targeting of SHP2 is being recognized as a potentially viable therapeutic option in HER2-positive and triple-negative breast cancers. In this report, …

    wvu Repository record for Exploring the mechanism of SHP2 and EGFR/HER2 cooperation in breast cancer cell signaling (opens in a new tab)

  5. Bioimage informatics for understanding the effects of chemotherapy on cellular signaling, structure, and function

    … but its effects are often associated with cancer relapse, metastasis, and drug resistance. The biological mechanisms that drive the structural and functional changes in cancer cells associated with these features of disease progression remain poorly understood. Consequently, quantitative …

    mit Repository record for Bioimage informatics for understanding the effects of chemotherapy on cellular signaling, structure, and function (opens in a new tab)

  6. Synergistic Effects Of Garcinol And Gemcitabine In Enhancing Therapeutic Efficacy In Pancreatic Adenocarcinoma Cells And Its Effect On Microrna Profile

    … DOCTOR OF PHILOSPHY</p> <p>Human Pancreatic Cancer (PaCa) is one of the most hostile and fourth leading cause of cancer deaths in the United States. Current standard chemotherapeutic agent for advanced PaCa is gemcitabine, a cytotoxic nucleoside analogue which results in modest response due …

    wayne-thes Repository record for Synergistic Effects Of Garcinol And Gemcitabine In Enhancing Therapeutic Efficacy In Pancreatic Adenocarcinoma Cells And Its Effect On Microrna Profile (opens in a new tab)

  7. Molecular mechanisms of KRas4b signaling

    Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2027-05-01

    uiuc Repository record for Molecular mechanisms of KRas4b signaling (opens in a new tab)

  8. Unraveling Host-Gut Microbiota Dialogue and Its Impact On Response to Immune Checkpoint Blockade

    <p>Cancer is a disease with only one degree of separation, affecting one in two men and one in three women in their lifetimes; accounting for 1 of every 6 deaths. While cancer mortality rates continue to improve, incidence rates are expected to rise and shift through 2050 due to epidemiological and …

    uthsc Repository record for Unraveling Host-Gut Microbiota Dialogue and Its Impact On Response to Immune Checkpoint Blockade (opens in a new tab)

  9. Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma

    … found in several different types of human cancers, such as nucleophosmin-anaplastic lymphoma kinase-expressing anaplastic large-cell lymphoma (NPM-ALK<sup>+ </sup>ALCL). The oncogenic potential of NPM-ALK has been demonstrated by several studies using <em>in vitro</em> assays as well as …

    uthsc Repository record for Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma (opens in a new tab)

  10. The Cell Membrane Proteome of the SKBR3/HER2+ Cells and Implications for Cancer Targeted Therapies

    Breast cancer is the second most common type of cancer among women in the US and the second leading cause of cancer death. HER2+ breast cancers represent ~20% of all cancer types, are highly invasive, and can be treated by using targeted therapies against the HER2 receptor. However, these therapies …

    vt Repository record for The Cell Membrane Proteome of the SKBR3/HER2+ Cells and Implications for Cancer Targeted Therapies (opens in a new tab)